Роль малых дыхательных путей при бронхиальной астме
https://doi.org/10.18093/0869-0189-2010-6-87-97
Список литературы
1. Mannino D.M., Homa D.M., Akinbami L.I. et al. Surveil� lance of asthma - United States, 1980-1990. Morb. Mort. Wkly Rep. Surveill. Summ. 2002; 51: 1-13
2. Global initiative for asthma: Global strategy for asthma management and prevention. NHLBI / WHO Workshop Report. Updated 2009. Available at: http://www.ginasthma. com
3. Bateman E.D., Boushey H.A., Bousquet J. et al. Can guide� line�defined asthma control be achieved? The gaining opti� mal asthma control study. Am. J. Respir. Crit. Care Med. 2004; 170: 836-844
4. Morgan W.J., Stern D.A., Sherrill D.L. et al. Outcome of asthma and wheezing in the first 6 years of life: follow�up through adolescence. Am. J. Respir. Crit. Care Med. 2005; 172: 1253-1258
5. Van Ganse E., Laforest L., Pietri G. et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur. Respir. J. 2002; 20: 260-267
6. Van Ganse E., Antonicelli L., Zhang Q. et al. Asthma�related resource use and cost by GINA classification of severity in three European countries. Respir. Med. 2006; 100: 140-147
7. Burgel P.R., de Blic J., Chanez P. et al. Update on the roles of distal airways in asthma. Eur. Respir. Rev. 2009; 18: 80-95
8. Hyde D.M., Hamid Q., Irvin C.G. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J. Allergy Clin. Immunol. 2009; 124: 72-77
9. Contoli M., Bousquet J., Fabbri L.M. et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 65: 141-151
10. Weibel E.R. Morphometry of the human lung. New York: Academic Press; 1963
11. Wright J.L. Small airway diseases: its role in chronic airway obstruction. Semin. Respir. Med. 1992; 13: 72-84
12. Garg K., Lynch D.A., Newell J.D., King T.E. Proliferative and constrictive bronchiolitis: classification and radiological features. Am. J. Roentgenol. 1994; 162: 803-808
13. Macklem P.T., Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J. Appl. Physiol. 1967, 22: 395-401
14. Macklem P.T., Mead J. Factors determining maximum expiratory flow in dogs. J. Appl. Physiol. 1968, 25: 159-169
15. Van Brabandt H., Cauberghs M., Verbeken E. et al. Partitioning of pulmonary impedance in excised human and canine lungs. J. Appl. Physiol. 1983, 55: 1733-1742
16. Wagner E.M., Liu M.C., Weinmann G.G. et al. Peripheral lung resistance in normal and asthmatic subjects. Am. Rev. Respir. Dis. 1990; 148: 584-588
17. Wagner E.M., Bleecker E.R., Permutt S. et al. Direct assess� ment of small airways reactivity in human subjects. Am. J. Respir. Crit. Care Med. 1998; 157: 447-452
18. Yanai M., Sekizawa K., Ohrui T. et al. Site of airway obstruc� tion in pulmonary disease: direct measurement of intra� bronchial partition the central and peripheral airway resist� ance in a pressure. J. Appl. Physiol. 1992; 72: 1016-1023
19. Gibson G.J. Pulmonary hyperinflation a clinical overview. Eur. Respir. J. 1996; 9: 2640-2649
20. Sorkness R.L., Bleecker E.R., Busse W.W. et al. Lung func� tion in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J. Appl. Physiol. 2008; 104: 394-403
21. Wenzel S.E., Schwartz L.B., Langmack E.L. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 1999; 160: 1001-1008
22. Marseglia G.L., Cirillo I., Vizzaccaro A. et al. Role of forced expiratory flow at 25-75 % as an early marker of small air� ways impairment in subjects with allergic rhinitis. Allergy Asthma Proc. 2007; 28: 74-78
23. Hansen J.E., Sun X.G., Wasserman K. Discriminating meas� ures and normal values for expiratory obstruction. Chest 2006; 129: 369-377
24. Pellegrino R., Viegi G., Brusasco V. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26: 948-968
25. Bourdin A., Paganin F., Prefaut C. et al. Nitrogen washout slope in poorly controlled asthma. Allergy 2006; 61: 85-89
26. Make B., Lapp N.L. Factors influencing the measurement of closing volume. Am. Rev. Respir. Dis. 1975; 111: 749-754
27. McFadden E.R., Holmes B., Kiser R. Variability of closing volume measurements in normal man. Am. Rev. Respir. Dis. 1975; 111: 135-140
28. Antic R., Macklem P.T. The influence of clinical factors on the site of airway obstruction in asthma. Am. Rev. Respir. Dis. 1976; 114: 851-859
29. Berend N., Nelson A., Rutland M.B. et al. The maximum expiratory flow�volume curve with air and a low�density gas mixture. An analysis of subject and observer variability. Chest 1981; 80: 23-30
30. Zack R.T., Solliday N.H., Celik L. et al. Variability of the volume of isoflow. Chest 1981; 79: 269-272
31. Saadeh C., Goldman M., Gaylor P. Forced oscillation using impulse oscillometry (IOS) detects false negative spirometry in symptomatic patients with reactive airways. J. Allergy Clin. Immun. 2003; 111: 136
32. Landser F.J., Clement J., Van de Woestijne K.P. Normal val� ues of total respiratory resistance and reactance determined by forced oscillations: influence of smoking. Chest 1982; 81: 586-591
33. Mahut B., Delacourt C., ZerahLancner F. et al. Increase in alveolar nitric oxide in the presence of symptoms in child� hood asthma. Chest 2004; 125: 1012-1018
34. Battaglia S., den Hertog H., Timmers M.C. et al. Small air� ways function and molecular markers in exhaled air in mild asthma. Thorax 2005; 60: 639-644
35. King G.G., Muller N.L., Par P.D. Evaluation of airways in obstructive pulmonary disease using high�resolution com� puted tomography. Am. J. Respir. Crit. Care Med. 1999; 159: 992-1004
36. Lynch D.A., Newell J.D., Tschomper B.A. et al. Uncompli� cated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993; 188: 829-833
37. Park J.W., Hong Y.K., Kim C.W. et al. High�resolution com� puted tomography in patients with bronchial asthma: corre� lation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J. Investig. Allergol. Clin. Immunol. 1997; 7: 186-192
38. McNittGray M.F., Goldin J.G., Johnson T.D. et al. Development and testing of image�processing methods for the quantitative assessment of airway hyperresponsiveness from high�resolution CT images. J. Comput. Assist. Tomogr. 1997; 21: 939-947
39. Goldin J.G., McNittGray M.F., Sorenson S.M. et al. Airway hyperreactivity assessment with helical thin�section C. Radiology 1998; 208: 321-329
40. Goldin J.G., McNittGray M.F. Johnson T. et al. Functional helical high�resolution CT: sensitive test for detecting air trapping due to reversible airway hyperreactivity. Radiology 1995; 197 (P): 437
41. Laurent F., Latrabe V., Raherison C. et al. Functional signif� icance of air trapping detected in moderate asthma. Eur. Radiol. 2000; 10: 1404-1410
42. Jensen S.P., Lynch D.A., Brown K.K. et al. High�resolution CT features of severe asthma and bronchiolitis obliterans. Clin. Radiol. 2002; 57: 1078-1085
43. Ueda T., Niimi A., Matsumoto H. et al. Role of small airways in asthma: investigation using high�resolution computed tomog� raphy. J. Allergy Clin. Immunol. 2006; 118: 1019-1025
44. Jain N., Covar R.A., Gleason M.C. et al. Quantitative com� puted tomography detects peripheral airway disease in asth� matic children. Pediatr. Pulmonol. 2005; 40: 211-218
45. Lee Y.M., Park J.S., Hwang J.H. et al. High�resolution CT findings in patients with near�fatal asthma: comparison of patients with mild�to�severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004; 126: 1840-1848
46. Goldin J.G.,Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267
47. Yablonskiy D.A., Sukstanskii A.L., Leawoods J.C. et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc. Natl. Acad. Sci. USA 2002; 99: 3111-3116
48. Samee S., Altes T., Powers P. et al. Imaging the lungs in asth� matic patients by using hyperpolarized helium�3 magnetic resonance: assessment of response to methacholine and exercise challenge. J. Allergy Clin. Immunol. 2003; 111: 1205-1211
49. Kauczor H.U., Chen X.J., van Beek E.J., Schreiber W.G. Pulmonary ventilation imaged bymagnetic resonance: at the doorstep of clinical application. Eur. Respir. J. 2001; 17: 1008-1023
50. de Lange E.E., Altes T.A., Patrie J.T. et al. Evaluation of asthma with hyperpolarized helium�3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130: 1055-1062
51. Holz O., Jorres R.A., Magnussen H. Monitoring central and peripheral airway inflammation in asthma. Respir. Med. 2000; 94 (Suppl. D): 7-12
52. Huber H.L., Koessle K. The pathology of bronchial asthma. Arch. Intern. Med. 1922; 30: 689-760
53. Saetta M., DeStefano A., Rosina C. et al. Quantitative struc� tural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 1991; 143: 138-143
54. Kuwano K., Bosken C.H., Pare P.D. et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1993; 148: 1220-1225
55. Haley K.J., Sunday M.E., Wiggs B.R. et al. Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 1998; 158: 565-572
56. de Magalhäes Simöes S., dos Santos M.A. et al. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clin. Exp. Allergy 2005; 35: 602-611
57. de Medeiros Matsushita M., da Silva L.F., dos Santos M.A. et al. Airway proteoglycans are differentially altered in fatal asth� ma. J. Pathol. 2005; 207: 102-110
58. Dolhnikoff M., da Silva L.F., de Araujo B.B. et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 2009; 123: 1090-1097
59. Mauad T., Silva L.F., Santos M.A. et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 2004; 170: 857-862
60. Shiang C., Mauad T., Senhorini A. et al. Pulmonary periar� terial inflammation in fatal asthma. Clin. Exp. Allergy 2009; 39: 1499-1507
61. Hamid Q., Song Y., Kotsimbos T.C. et al. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 1997; 100: 44-51
62. Hamid Q. Peripheral inflammation is more important than central inflammation. Respir. Med. 1997: 91 (Suppl. A): 11-12
63. Kraft M., Djukanovic R., Wilson S. et al. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 1505-1510
64. McFadden E.R., Kiser R., DeGroot W.J. Acute bronchial asthma. Relations between clinical and physiologic meas� ures. N. Engl. J. Med. 1973; 288: 221-225
65. Kraft M., Pak J., Martin R.J. et al. Distal lung dysfunction at night in nocturnal asthma. Am. J. Respir. Crit. Care Med. 2001; 163: 1551-1556
66. Lange P., Parner J., Vestbo J. et al. A 15�year follow�up study of ventilatory function in adults with asthma. N. Engl. J. Med. 1998; 339: 1194-1200
67. Peat J.K., Woolcock A.J., Culle K. Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 1987; 70: 171-179
68. in't Veen J.C., Beekman A.J., Bel E.H. et al. Recurrent exac� erbations in severe asthma are associated with enhanced air� way closure during stable episodes. Am. J. Respir. Crit. Care Med. 2000; 161: 1902-1906
69. van Veen I.H., Sterk P.J., Schot R. et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur. Respir. J. 2006; 27: 951-956
70. Leach C.L. Improved delivery of inhaled steroids to the large and small airways. Respir. Med. 1998; 92 (Suppl. A): 3-8
71. Lipworth B.J. Targets for inhaled drugs. Respir. Med. 2000; 94 (Suppl. D): S13-S16
72. Worth H., Muir J.F., Pieters W.R. Comparison of hydroflu� oroalkane�beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration 2001; 68: 517-526
73. Reichel W., Dahl R., Ringdal N. et al. Extrafine beclometha� sone dipropionate breath�actuated inhaler (400 micrograms / day) versus budesonide dry powder inhaler (800 micrograms / day) in asthma. Int. J. Clin. Pract. 2001; 55: 100-106
74. Ederle K. Multicentre Study Group. Improved control of asthma symptoms with a reduced dose of HFA�BDP extrafine aerosol: an open�label, randomised study. Eur. Rev. Med. Pharmacol. Sci. 2003; 7: 45-55
75. Davies R.J., Stampone P., O'Connor B.J. Hydrofluoro� alkane�134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir. Med. 1998; 92 (Suppl. A): 23-31
76. Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000; 37: 389-398
77. Fowler S.J., Currie G.P., Lipworth B.J. Step�down therapy with low�dose fluticasone�salmeterol combination or medi� um�dose hydrofluoroalkane 134a�beclomethasone alone. J. Allergy Clin. Immunol. 2002; 109: 929-935
78. Molimard M., Martinat Y., Rogeaux Y. et al. Improvement of asthma control with beclomethasone extrafine aerosol com� pared to fluticasone and budesonide. Respir. Med. 2005; 99: 770-778
79. Busse W.W., Brazinsky S., Jacobson K. et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is propor� tional to dose and is improved by formulation with a new pro� pellant. J. Allergy Clin. Immunol. 1999; 104: 1215-1222
80. Goldin J.G., Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267
81. Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000: 37 (5): 389-398
82. Ohbayashi H. One�year evaluation of the preventative effect of hydrofluoroalkane�beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007: 74: 146-153
83. Dhillon S., Keating G.M. Beclometasone dipropionate / for� motherol. In an HFA�propelled pressurized metered�dose inhaler. Drugs 2006; 66: 1475-1483
84. Bousquet J., Poli G., Acerbi D. et al. Systemic exposure and implications for lung deposition with extra�fine HFA beclometasone dipropionat / formoterol fixed combination. Clin. Pharmacokinet. 2009; 48: 347-358
85. De Backer W., Devolder A., Poli G. et al. Lung deposition of BDP / formoterol HFA pMDI in healthy volunteers, asth� matic, and COPD patients. J. Aerosol Med. Pulm. Drug Deliv. 2010; 23: 137-148
86. BonnetGonod F., Kottakis I., Ballabio M. et al. Superior efficacy of a low daily dose of a new fixed combination of beclometasone dipropionate / formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study. 16th Annual Congress of the European Respiratory Society; 2006 Sep. 2-6; Munich: P1237
87. Huchon G., Magnussen H., Chuchalin A. et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir. Med. 2009; 103: 41-49
88. Scichilone N., Battaglia S., Sorino C. et al. Effects of extra� fine inhaled beclomethasone / formoterol on both large and small airways in asthma. Allergy 2010; 65: 897-902
89. Papi A., Paggiaro P., Nicolini G. et al. Beclomethasone / for� moterol vs fluticasone / salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62: 1182-1188
90. Papi A., Paggiaro P.L., Nicolini G. et al. Beclomethasone / formoterol versus budesonide / formoterol combination therapy in asthma. Eur. Respir. J. 2007; 29: 682-689
Рецензия
Для цитирования:
Авдеев С.Н. Роль малых дыхательных путей при бронхиальной астме. Пульмонология. 2010;(6):87-97. https://doi.org/10.18093/0869-0189-2010-6-87-97